127
Participants
Start Date
September 15, 2023
Primary Completion Date
May 31, 2030
Study Completion Date
August 31, 2030
TARA-002
All participants will receive 6 weekly instillations of TARA-002 at the established RP2D (First Treatment Period). Participants who are eligible for reinduction after the First Treatment Period will receive 6 additional weekly doses of TARA-002 instillation as part of the Second Treatment Period. Participants confirmed to have a complete response after the First Treatment Period will receive 3 additional weekly doses of TARA-002 instillation as maintenance during the Second Treatment Period. All eligible participants will receive 3 weekly doses of TARA-002 instillation as part of the Third Treatment Period (maintenance) at Months 6, 9, 12, 15, and 18. Following the Third Treatment Period, all participants will continue to the Follow up Period from Month 21 until Month 60.
RECRUITING
Clinica Privada Independencia, Munro
RECRUITING
Montefiore Medical Center, The Bronx
TERMINATED
AccuMed Research Associates, Garden City
RECRUITING
University of Rochester, Department of Urology, Rochester
RECRUITING
Virginia Urology, Richmond
RECRUITING
Carolina Urologic Research Center, Myrtle Beach
RECRUITING
Mayo Clinic, Jacksonville
RECRUITING
University of Florida Health Jacksonville, Gainesville
RECRUITING
Urology Associates PC, Nashville
RECRUITING
Conrad Person Clinic, Memphis
RECRUITING
University of Toledo, Toledo
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Southern Urology, Lafayette
WITHDRAWN
Ochsner Health LSU - Regional Urology, Shreveport
RECRUITING
Urology Partners of North Texas, Arlington
RECRUITING
Houston Metro Urology, Houston
RECRUITING
Houston Methodist Hospital, Houston
WITHDRAWN
Clinical Trial Network, Houston
RECRUITING
UT Health San Antonio, San Antonio
RECRUITING
Urology Austin, LLC, Austin
RECRUITING
Colorado University - Anshutz, Aurora
RECRUITING
Urology Associates of Denver, Lone Tree
RECRUITING
Advanced Urology, Lakewood
RECRUITING
Mayo Clinic, Phoenix
RECRUITING
Urology Group of Southern California, Los Angeles
WITHDRAWN
Genesis Research, San Diego
RECRUITING
University of California Irvine Medical Center, Orange
RECRUITING
Brigham and Women's Hospital, Boston
RECRUITING
Centro Argentino de Urologia, CABA
RECRUITING
Hospital Sirio Libanes, CABA
RECRUITING
Centro Urologico Profesor Bengio SA, Córdoba
RECRUITING
CEMAIC, Córdoba
RECRUITING
Santa Casa de Misericordia de Porto Alegre, Porto Alegre
RECRUITING
Nucleo de Pesquisa Clinica do Rio Grande so Sul, Porto Alegre
RECRUITING
Instituto Dor de Pesquisa e Ensino, Jardim Paulista
RECRUITING
Faculdade de Medicina ABC-CEPHO, Santo André
RECRUITING
Exdeo Clinical Research Inc, Abbotsford
WITHDRAWN
Jonathan Giddes Medicine Professional Corporation, Brampton
WITHDRAWN
Sunnybrook Research Institute, Toronto
RECRUITING
UHN Princess Margaret Cancer Centre Princess Margaret Hospital, Toronto
RECRUITING
Tokyo University Medical Center Sakura Hospital, Fuji-shi
RECRUITING
Arensia Kapitanivka - PPDS, Kapitanivka
Lead Sponsor
Protara Therapeutics
INDUSTRY